In a news release from early February 2022, clinical-stage pharmaceutical development company Algernon Pharmaceuticals Inc. ("Algernon") shared that its Phase 2 clinical trial evaluating Ifenprodil (NP-120) was fully enrolled. Within…
The Marfan Foundation has a mission to improve the quality of life for patients living with Marfan syndrome and other aortic and vascular conditions. This month, in honor of Marfan Syndrome…
On February 7, 2022, Healthline reported that the FDA had approved Vabysmo (faricimab-svoa), an injectable therapy for those with wet age-relate macular degeneration (wAMD) and diabetic macular edema. This approval…
A tragedy in Deer Creek, Oklahoma has pushed bacterial meningitis into the spotlight after it claimed the life of Nathan Rogalski. Nathan, who was a star athlete within his community,…
According to a recent article, researchers have conducted a pilot human trial to test out a falloposcope which captures images of the fallopian tubes in patients, which will hopefully enable…
If you would like to read the first part of this interview, please take a look at Part 1 here. In the first part of the interview, I spoke with…
The Ebola virus is endemic in certain areas of Africa, where viral outbreaks still exist to this day. For example, there were at least three Ebola outbreaks in Africa during…
February 15, 2013 marked the first-ever International Angelman Day. The day, still celebrated nine years later, aims to raise global awareness for Angelman syndrome. Additionally, International Angelman Day serves to…
© Copyright 2024 Patient Worthy
Sign Up With a Patient Worthy Account and Share Your Rare Story
- OR -
Make a difference, share your experiences and get paid. Opt-in and join Patient Worthy's panel for paid opportunities such as surveys, market research, patient advisory panels and more.
- OR -
Make a difference, share your experiences and get paid. Opt-in and join Patient Worthy's panel for paid opportunities such as surveys, market research, patient advisory panels and more.
